In Episode 01 of INSIDE CDMO: BEHIND THE GLASS, we sit down with Eduard Viladesau, Managing Director of HIPRA Biotech Services, to explore the reality of building and operating a biologics CDMO.
HIPRA Biotech Services provides development and manufacturing services across mammalian, microbial and aseptic fill-and-finish platforms, with capabilities spanning development through clinical and commercial manufacturing.
What This Episode Covers
🔹 How HIPRA built a new CDMO business around decades of biologics experience
🔹 What Eduard learned moving from BCG consulting to operating the business himself
🔹 How a new CDMO wins its first clients and builds trust
🔹 The challenge of balancing commercial growth with delivery and operational readiness
🔹 Where AI can improve CDMO operations and why adoption needs to be responsible and secure
ft - Ravindra Warang
31 min
ft - Dr. Mahesh Bhalgat
28 min

ft - Dr. Tathagata Dutta
60 min
ft - Dr. Paul Faulder
05:36 min
ft - Ravindra Warang
31 min
ft - Dr. Mahesh Bhalgat
28 min

ft - Dr. Tathagata Dutta
60 min
ft - Dr. Paul Faulder
05:36 min